Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Duffy

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Trends in Cardiovascular Medicine|February 13, 2007
Endocannabinoid antagonism: blocking the excess in the treatment of high-risk abdominal obesityDanielle Duffy, Daniel Rader
Journal of Cardiopulmonary Rehabilitation|April 18, 2006
High-density lipoprotein cholesterol therapies: the next frontier in lipid managementDanielle Duffy, Daniel J Rader
Current Opinion in Cardiology|June 16, 2005
Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Trends in Cardiovascular Medicine|December 2, 2014
2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease riskJonathan B Finkel, Danielle Duffy
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
Current Atherosclerosis Reports|March 5, 2015
Targeting lipoprotein (a): an evolving therapeutic landscapeLillian C Man, Erik Kelly, Danielle Duffy
Delaware Medical Journal|September 26, 2015
Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical PracticeJeffrey A Marbach, Jhapat Thapa, Edward Goldenberg, et al.
Expert Review of Cardiovascular Therapy|October 11, 2014
PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersDanielle Duffy, Bridget Rooney, Suzanne Adams, et al.
Postgraduate Medicine|January 8, 2014
Aspirin for cardioprotection and strategies to improve patient adherenceDanielle Duffy, Erik Kelly, Amanda Trang, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Trends in Cardiovascular Medicine|February 13, 2007
Endocannabinoid antagonism: blocking the excess in the treatment of high-risk abdominal obesityDanielle Duffy, Daniel Rader
Journal of Cardiopulmonary Rehabilitation|April 18, 2006
High-density lipoprotein cholesterol therapies: the next frontier in lipid managementDanielle Duffy, Daniel J Rader
Current Opinion in Cardiology|June 16, 2005
Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Trends in Cardiovascular Medicine|December 2, 2014
2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease riskJonathan B Finkel, Danielle Duffy
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
Current Atherosclerosis Reports|March 5, 2015
Targeting lipoprotein (a): an evolving therapeutic landscapeLillian C Man, Erik Kelly, Danielle Duffy
Delaware Medical Journal|September 26, 2015
Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical PracticeJeffrey A Marbach, Jhapat Thapa, Edward Goldenberg, et al.
Expert Review of Cardiovascular Therapy|October 11, 2014
PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersDanielle Duffy, Bridget Rooney, Suzanne Adams, et al.
Postgraduate Medicine|January 8, 2014
Aspirin for cardioprotection and strategies to improve patient adherenceDanielle Duffy, Erik Kelly, Amanda Trang, et al.
Pageof 5